SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Novo Holdings A/S (Last) (First) (Middle) TUBORG HAVNEVEJ 19 (Street) HELLERUP G7 2900 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 12/29/2022	3. Issuer Name and Ticker or Trading Symbol Disc Medicine, Inc. [ IRON ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X 10% Owner Officer (give title below) Other (specify below)	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
COMMON STOCK(1)	2,340,772(2)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Effective as of December 29, 2022 (the "Effective Time"), a wholly-owned subsidiary of Gemini Therapeutics, Inc. ("Gemini"), merged (the "Merger") with and into Disc Medicine, Inc. ("Disc") resulting in, among other things, Disc becoming a wholly owned subsidiary of Gemini. At the Effective Time, Gemini effected a name change to "Disc Medicine, Inc." (hereinafter, the "Issuer").

2. Represents the number of shares of common stock of the Issuer received by the Reporting Person in the Merger in exchange for the shares of Disc held by the Reporting Person prior to the Merger. Each share of Disc common stock held at the Effective Time was exchanged for 0.1096 shares of the Issuer's common stock, which gives effect to the reverse split of common stock effected by the Issuer and the Merger exchange ratio.

Remarks:

	/s/ Barbara Fiorini Due, General Counsel, Finance and Operations	01/03/2023
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.